Biotest
Iris Bobenhausen has a diverse work experience in the clinical research field. Iris started their career at Novo Nordisk in 2007 as a Klinischer Monitor and later became a Clinical Trial Project Manager from 2009 to 2011. In 2012, they joined Biotest AG as a Clinical Trial Manager and was subsequently promoted to the position of Senior Clinical Manager from 2014 to 2016. Iris'smost recent role at Biotest AG was as an Associate Director of Clinical Research from 2016 to 2019. In 2019, Iris assumed the position of Director of Clinical Research Operations at Biotest AG.
Iris Bobenhausen holds a Doctor's Degree in Biology from Johannes Gutenberg University Mainz.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.